[Cyclosporine in the treatment of psoriasis].

Psoriasis is a chronic inflammatory skin disease of unknown etiology. An immune-reaction mediated by T lymphocytes is important in the pathogenesis. Cyclosporin is a selective immuno-suppressant that inhibits helper T lymphocytes. Several controlled clinical studies have shown that cyclosporin is highly effective in controlling severe psoriasis. The main side effects are hypertension, nephrotoxicity and increased risk of developing malignancies, particularly after long-term treatment. Side effects during short-term therapy appear to be reversible. Some questions connected to the long-term use and safety of cyclosporin are still unsolved.
AuthorsJ R Bjerke
JournalTidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række (Tidsskr Nor Laegeforen) Vol. 112 Issue 22 Pg. 2863-5 (Sep 20 1992) ISSN: 0029-2001 [Print] NORWAY
Vernacular TitleCyklosporin i behandlingen av psoriasis.
PMID1412327 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cyclosporine
  • Cyclosporine (adverse effects, pharmacokinetics, therapeutic use)
  • Humans
  • Psoriasis (drug therapy, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: